INSYTE with SurePlanTM LiverY90
INSYTE with SurePlanTM LiverY90
Collaboration between Sirtex Medical and MIM Software Inc. advances innovation and increases precision of liver-directed oncology therapies for patients.
MIM Software Inc. is the legal manufacturer of the SurePlan LiverY90 Software.
SurePlan is a trademark of MIM Software Inc.
![mim](/media/l4zpdkq5/mim.png?width=425&height=87&mode=max)
SIR-Spheres® Y-90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) or unresectable metastatic liver tumors from primary colorectal cancer (mCRC) in patients refractory to or intolerant of chemotherapy.
SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd.